CD59 efficiently protects human NT2-N neurons against complement-mediated damage (Q40106379)

17 September 2017

CD59 efficiently protects human NT2-N neurons against complement-mediated damage (English)

1 reference

17 September 2017

5

1 reference

17 September 2017

6

Mollnes TE

1 reference

17 September 2017

Pedersen ED

1

1 reference

17 September 2017

Aass HC

series ordinal

2

1 reference

17 September 2017

Rootwelt T

series ordinal

3

1 reference

17 September 2017

Fung M

series ordinal

4

1 reference

17 September 2017

1 August 2007

1 reference

Scandinavian Journal of Immunology

17 September 2017

1 reference

17 September 2017

66

1 reference

17 September 2017

345-351

1 reference

17 September 2017

2-3

1 reference

Complement activation in the central nervous system following blood-brain barrier damage in man.

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Systemic complement activation following human acute ischaemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Induced expression of neuronal membrane attack complex and cell death by Alzheimer's beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Spontaneous classical pathway activation and deficiency of membrane regulators render human neurons susceptible to complement lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Activation of the lectin pathway by natural IgM in a model of ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

The GABAA receptor is expressed in human neurons derived from a teratocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Differential gene expression between human neurons and neuronal progenitor cells in culture: an analysis of arrayed cDNA clones in NTera2 human embryonal carcinoma cell line as a model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Critical protection from renal ischemia reperfusion injury by CD55 and CD59.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

The powerful neuroprotective action of C1-inhibitor on brain ischemia-reperfusion injury does not require C1q

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Complement inhibition does not reduce post-hypoxic-ischemic cerebral injury in 21-day-old rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Role of natural and immune IgM antibodies in immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

Generation of C5a in the absence of C3: a new complement activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2007.01959.X

10.1111/J.1365-3083.2007.01959.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference